Location
Israel, Middle East
Cheque size
$200K - $1.4M
Investment Stage
Focus Areas
About Investor
Steve Rhodes is Co-Founder and Chair Emeritus of The Trendlines Group (SGX: 42T), an Israel-based innovation incubator and investment group he co-founded in 2007 with Todd Dollinger, focused on creating and building early-stage medtech and agrifood companies. Under Rhodes and Dollinger's leadership, Trendlines completed an IPO on the Singapore Stock Exchange (2015), took two portfolio companies public on the Tel Aviv Stock Exchange (E.T.View Medical and FlowSense Medical), founded 90+ companies, and exited portfolio companies to multinational corporations. Steve stepped down as Co-CEO in November 2023, transitioning to Chair/Chair Emeritus roles. He currently serves as Chair of Trendlines Investments Israel, Investment Committee Chair of Trendlines Medical Singapore, and Chair of the Trendlines Agrifood Fund and Agrifood Innovation Centre (AFIC) in Singapore. His career began at Bank Leumi Chicago in 1979, advancing through finance and marketing roles. He holds an MBA in Finance from the University of Chicago Booth School of Business and an AB in History from Harvard University. Based in Acre (Akko), northern Israel.
Similar Investors
Noah Pickholtz
Idea
,Pre Seed
,Tomer Warschauer Nuni
Pre Seed
,Seed
,Ariel Finkelstein
Pre Seed
,Seed
,Yaniv Golan
Pre Seed
,Seed
,Barak Kaufman
Pre Seed
,Seed
,Daniel Recanati
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.